AddLife company profile
Company profile
AddLife has 2,428 employees and is headquartered in Stockholm, Sweden.
Laboratory analytical instruments, microscopes, consumables and reagents, together with medical devices for surgery, orthopaedics, endoscopy and wound care, form the core of AddLife's offering. Its Labtech segment serves diagnostics and biomedical research, with products spanning microbiology, clinical chemistry, molecular biology, immunology and veterinary diagnostics, and it also provides training for customers. The Medtech segment covers critical care, ophthalmology, healthcare IT and assistive devices for the elderly and disabled. Customers include medical care providers, research institutions, colleges and universities, and food and pharmaceutical companies, with operations in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland and Austria, among other European and international markets.
In the fiscal year ended December 2025, AddLife reported revenue of 10.4 billion SEK, up 1.5% from the previous year, and net income of 560 million SEK. The group employed 2,428 people. It is headquartered in Stockholm, Sweden, and was founded in 1906.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Sweden
- Headquarters
- Brunkebergstorg 5, 103 62, Stockholm
- Employees
- 2,428
- Chief executive
- Fredrik Dalborg
- Founded
- 1906
- Fiscal year
- January - December
- Listing
- ALIF.B · Nasdaq Stockholm
- Currency
- SEK
- ISIN
- SE0014401378
- Website
- add.life
AddLife and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| AddLifeALIF.B | Sweden | $2.11B | 2,428 | 8.9% | 33.5 |
| Bonesupport HoldingBONEX | Sweden | $2.03B | 174 | 25.5% | 78.1 |
| OttobockOBCK | Germany | $2.68B | 9,455 | 18.7% | 19.0 |
| Carl Zeiss MeditecAFX | Germany | $3.07B | 5,784 | 7.2% | 23.3 |
| Tecan GroupTECN | Switzerland | $3.58B | 3,000 | 4.9% | — |
| GerresheimerGXI | Germany | $1.19B | 13,301 | 1.6% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
